• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新兴的 Leber 遗传性视神经病变模型系统和治疗方法:挑战与机遇。

Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities.

机构信息

University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, United States of America.

University of the Incarnate Word School of Medicine, 7615 Kennedy Hill Drive, San Antonio, TX 78235, United States of America.

出版信息

Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165743. doi: 10.1016/j.bbadis.2020.165743. Epub 2020 Feb 24.

DOI:10.1016/j.bbadis.2020.165743
PMID:32105823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9252426/
Abstract

Leber's hereditary optic neuropathy (LHON) is a mitochondrial disease mainly affecting retinal ganglion cells (RGCs). The pathogenesis of LHON remains ill-characterized due to a historic lack of effective disease models. Promising models have recently begun to emerge; however, less effective models remain popular. Many such models represent LHON using non-neuronal cells or assume that mutant mtDNA alone is sufficient to model the disease. This is problematic because context-specific factors play a significant role in LHON pathogenesis, as the mtDNA mutation itself is necessary but not sufficient to cause LHON. Effective models of LHON should be capable of demonstrating processes that distinguish healthy carrier cells from diseased cells. In light of these considerations, we review the pathophysiology of LHON as it relates to old, new and future models. We further discuss treatments for LHON and unanswered questions that might be explored using these new model systems.

摘要

Leber 遗传性视神经病变(LHON)是一种主要影响视网膜神经节细胞(RGC)的线粒体疾病。由于历史上缺乏有效的疾病模型,LHON 的发病机制仍不清楚。最近有一些有前途的模型开始出现;然而,效果较差的模型仍然很受欢迎。许多此类模型使用非神经元细胞来代表 LHON,或者假设突变的 mtDNA 本身足以模拟疾病。这是有问题的,因为特定于上下文的因素在 LHON 的发病机制中起着重要作用,因为 mtDNA 突变本身是必要的,但不足以导致 LHON。有效的 LHON 模型应该能够证明区分健康载体细胞与患病细胞的过程。有鉴于此,我们回顾了 LHON 的病理生理学,以及与旧模型、新模型和未来模型的关系。我们进一步讨论了 LHON 的治疗方法以及使用这些新模型系统可能探索的未解决问题。

相似文献

1
Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities.新兴的 Leber 遗传性视神经病变模型系统和治疗方法:挑战与机遇。
Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165743. doi: 10.1016/j.bbadis.2020.165743. Epub 2020 Feb 24.
2
Mitochondrial transport mediates survival of retinal ganglion cells in affected LHON patients.线粒体转运介导受影响的Leber遗传性视神经病变(LHON)患者视网膜神经节细胞的存活。
Hum Mol Genet. 2020 Jun 3;29(9):1454-1464. doi: 10.1093/hmg/ddaa063.
3
Bioactivity and gene expression profiles of hiPSC-generated retinal ganglion cells in MT-ND4 mutated Leber's hereditary optic neuropathy.MT-ND4 突变的莱伯遗传性视神经病变中 hiPSC 生成的视网膜神经节细胞的生物活性和基因表达谱。
Exp Cell Res. 2018 Feb 15;363(2):299-309. doi: 10.1016/j.yexcr.2018.01.020.
4
Inhibition of angiogenesis by the secretome from iPSC-derived retinal ganglion cells with Leber's hereditary optic neuropathy-like phenotypes.iPSC 衍生的具有 Leber 遗传性视神经病变样表型的视网膜神经节细胞分泌组抑制血管生成。
Biomed Pharmacother. 2024 Sep;178:117270. doi: 10.1016/j.biopha.2024.117270. Epub 2024 Aug 11.
5
Glutamate Stimulation Dysregulates AMPA Receptors-Induced Signal Transduction Pathway in Leber's Inherited Optic Neuropathy Patient-Specific hiPSC-Derived Retinal Ganglion Cells.谷氨酸刺激失调导致 Leber 遗传性视神经病变患者特异性 hiPSC 衍生的视网膜神经节细胞中 AMPA 受体诱导的信号转导通路异常。
Cells. 2019 Jun 21;8(6):625. doi: 10.3390/cells8060625.
6
Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy.莱伯遗传性视神经病变诱导多能干细胞模型中的线粒体替代
Aging (Albany NY). 2017 Apr;9(4):1341-1350. doi: 10.18632/aging.101231.
7
Nuclear modifier YARS2 allele correction restored retinal ganglion cells-specific deficiencies in Leber's hereditary optic neuropathy.核修饰基因 YARS2 等位基因校正恢复莱伯遗传性视神经病变中视网膜神经节细胞特异性缺陷。
Hum Mol Genet. 2023 Apr 20;32(9):1539-1551. doi: 10.1093/hmg/ddad001.
8
Pathological mitophagy disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy.病理性自噬破坏 Leber 遗传性视神经病变中线粒体的动态平衡。
Cell Rep. 2022 Jul 19;40(3):111124. doi: 10.1016/j.celrep.2022.111124.
9
Comparison of retinal nerve fibre layers between 11778 and 14484 mutations in Leber's hereditary optic neuropathy.莱伯遗传性视神经病变中 11778 号和 14484 号突变的视网膜神经纤维层比较。
Eye (Lond). 2010 Jan;24(1):107-11. doi: 10.1038/eye.2009.36. Epub 2009 Feb 27.
10
Whole mitochondrial genome analysis in South Indian patients with Leber's hereditary optic neuropathy.对南印度莱伯遗传性视神经病变患者的整个线粒体基因组进行分析。
Mitochondrion. 2017 Sep;36:21-28. doi: 10.1016/j.mito.2016.10.006. Epub 2016 Oct 28.

引用本文的文献

1
Technological advances in the diagnosis and management of inherited optic neuropathies.遗传性视神经病变诊断与管理的技术进展
Front Neurol. 2025 Jul 25;16:1609033. doi: 10.3389/fneur.2025.1609033. eCollection 2025.
2
Leber's hereditary optic neuropathy-associated ND1 3733G>C mutation ameliorates the mitochondrial quality control and cellular homeostasis.与Leber遗传性视神经病变相关的ND1基因3733G>C突变改善线粒体质量控制和细胞稳态。
J Biol Chem. 2025 Jul 8;301(8):110464. doi: 10.1016/j.jbc.2025.110464.
3
Vitamin A treatment restores vision failures arising from Leber's hereditary optic neuropathy-linked mtDNA mutation.

本文引用的文献

1
Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform.将类器官和器官芯片技术融合,在人眼芯片平台上生成复杂的多层组织模型。
Elife. 2019 Aug 27;8:e46188. doi: 10.7554/eLife.46188.
2
Elamipretide Improves Mitochondrial Function in the Failing Human Heart.依拉米肽可改善衰竭人心脏的线粒体功能。
JACC Basic Transl Sci. 2019 Apr 29;4(2):147-157. doi: 10.1016/j.jacbts.2018.12.005. eCollection 2019 Apr.
3
Propagation and Selectivity of Axonal Loss in Leber Hereditary Optic Neuropathy.
维生素A治疗可恢复由与莱伯遗传性视神经病变相关的线粒体DNA突变引起的视力障碍。
JCI Insight. 2025 Mar 4;10(8). doi: 10.1172/jci.insight.188962. eCollection 2025 Apr 22.
4
Looking to the Future of Viral Vectors in Ocular Gene Therapy: Clinical Review.展望眼部基因治疗中病毒载体的未来:临床综述
Biomedicines. 2025 Feb 5;13(2):365. doi: 10.3390/biomedicines13020365.
5
Applications of Machine Learning-Driven Molecular Models for Advancing Ophthalmic Precision Medicine.机器学习驱动的分子模型在推进眼科精准医学中的应用。
Bioengineering (Basel). 2025 Feb 6;12(2):156. doi: 10.3390/bioengineering12020156.
6
Preservation of Mitochondrial Function by SkQ1 in Skin Fibroblasts Derived from Patients with Leber's Hereditary Optic Neuropathy Is Associated with the PINK1/PRKN-Mediated Mitophagy.SkQ1对Leber遗传性视神经病变患者来源的皮肤成纤维细胞线粒体功能的保护作用与PINK1/PRKN介导的线粒体自噬相关。
Biomedicines. 2024 Sep 4;12(9):2020. doi: 10.3390/biomedicines12092020.
7
A case for the use of chemotherapy in hereditary mitochondrial optic neuropathies: Successful administration of cisplatin/etoposide in a male patient with testicular seminoma and Leber's hereditary optic neuropathy.遗传性线粒体视神经病变中使用化疗的病例报告:顺铂/依托泊苷成功治疗一名患有睾丸精原细胞瘤和Leber遗传性视神经病变的男性患者
Clin Case Rep. 2024 Jul 8;12(7):e9045. doi: 10.1002/ccr3.9045. eCollection 2024 Jul.
8
Mitochondrially Targeted Gene Therapy Rescues Visual Loss in a Mouse Model of Leber's Hereditary Optic Neuropathy.线粒体靶向基因治疗挽救 Leber 遗传性视神经病变小鼠模型的视力丧失。
Int J Mol Sci. 2023 Dec 2;24(23):17068. doi: 10.3390/ijms242317068.
9
Novel Role of Molecular Hydrogen: The End of Ophthalmic Diseases?分子氢的新作用:眼科疾病的终结?
Pharmaceuticals (Basel). 2023 Nov 7;16(11):1567. doi: 10.3390/ph16111567.
10
Continuous Hypoxia Reduces Retinal Ganglion Cell Degeneration in a Mouse Model of Mitochondrial Optic Neuropathy.持续缺氧可减少线粒体视神经病变小鼠模型中的视网膜神经节细胞变性。
Invest Ophthalmol Vis Sci. 2022 Dec 1;63(13):21. doi: 10.1167/iovs.63.13.21.
Leber 遗传性视神经病变中轴突损失的传播和选择性。
Sci Rep. 2019 Apr 30;9(1):6720. doi: 10.1038/s41598-019-43180-z.
4
NIPSNAP1 and NIPSNAP2 Act as "Eat Me" Signals for Mitophagy.NIPSNAP1 和 NIPSNAP2 作为线粒体自噬的“吃我”信号。
Dev Cell. 2019 May 20;49(4):509-525.e12. doi: 10.1016/j.devcel.2019.03.013. Epub 2019 Apr 11.
5
Prognostic factors for visual acuity in patients with Leber's hereditary optic neuropathy after rAAV2-ND4 gene therapy.rAAV2-ND4基因治疗后Leber遗传性视神经病变患者视力的预后因素
Clin Exp Ophthalmol. 2019 Aug;47(6):774-778. doi: 10.1111/ceo.13515. Epub 2019 May 8.
6
Hormone replacement therapy in Leber's hereditary optic neuropathy: Accelerated visual recovery in vivo.激素替代疗法治疗Leber遗传性视神经病变:体内视觉恢复加速
J Curr Ophthalmol. 2018 Nov 3;31(1):102-105. doi: 10.1016/j.joco.2018.10.003. eCollection 2019 Mar.
7
A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects.酵母基筛选测定法可识别出能抑制线粒体融合和 mtDNA 维持缺陷的再利用药物。
Dis Model Mech. 2019 Feb 7;12(2):dmm036558. doi: 10.1242/dmm.036558.
8
Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers.患有和未患有Leber遗传性视神经病变(LHON)突变携带者的线粒体DNA拷贝数。
BMC Res Notes. 2018 Dec 20;11(1):911. doi: 10.1186/s13104-018-4025-y.
9
Treatment strategies for Leber hereditary optic neuropathy.Leber 遗传性视神经病变的治疗策略。
Curr Opin Neurol. 2019 Feb;32(1):99-104. doi: 10.1097/WCO.0000000000000646.
10
Mitochondrial replacement therapy and assisted reproductive technology: A paradigm shift toward treatment of genetic diseases in gametes or in early embryos.线粒体替代疗法与辅助生殖技术:向配子或早期胚胎遗传疾病治疗的范式转变。
Reprod Med Biol. 2018 Sep 19;17(4):421-433. doi: 10.1002/rmb2.12230. eCollection 2018 Oct.